Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: A molecular epidemiologic study

Journal of Infectious Diseases

Volumn 211, Issue 5, 2015, Pages 680-688

  Taylor, Steve M ^a,b,c   Parobek, Christian M ^d   De Conti, Derrick K ^e   Kayentao, Kassoum ^h,i   Coulibaly, Sheick Oumar ^k   Greenwood, Brian M ^j   Tagbor, Harry ^l   Williams, John ^m   Bojang, Kalifa ⁿ   Njie, Fanta ⁿ   Desai, Meghna ^f,o   Kariuki, Simon ^p   Gutman, Julie ^f   Mathanga, Don P ^r   Mårtensson, Andreas ^s,t   Ngasala, Billy ^u   Conrad, Melissa D ^g   Rosenthal, Philip J ^g   Tshefu, Antoinette K ^v   Moormann, Ann M ^e   Vulule, John M ^q   Doumbo, Ogobara K ^h   Ter Kuile, Feiko O ^i,q   Meshnick, Steven R ^c   Bailey, Jeffrey A ^e   Juliano, Jonathan J ^d   more..

^a Division of Infectious Diseases   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c School of Public Health at the University   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Université des Sciences des Techniques et des Technologies de Bamako   (Mali)

ⁱ LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^l KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^m NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

ⁿ MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^o CDC Kenya   (Kenya)

^p KEMRI/CDC   (Kenya)

^q KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^r UNIVERSITY OF MALAWI   (Malawi)

^s Malaria Research   (Sweden)

^t KAROLINSKA INSTITUTE   (Sweden)

^u MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^v UNIVERSITY OF KINSHASA   (Congo)

more..

Author keywords

Artemisinin resistance; Drug resistance; Falciparum malaria; Molecular epidemiology

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; GENE FREQUENCY; GENETIC CODE; GENETIC DISTANCE; GENETIC STRAIN; GENOTYPE; GEOGRAPHIC DISTRIBUTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PLASMODIUM FALCIPARUM; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; SPECIES DISTRIBUTION; ADULT; CHILD; DRUG EFFECTS; EPIDEMIOLOGY; FEMALE; GENETIC POLYMORPHISM; HIGH THROUGHPUT SEQUENCING; HUMAN; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MALE; MUTATION; PARASITOLOGY; PREGNANCY; PRESCHOOL CHILD;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALARIA, FALCIPARUM; MALE; MOLECULAR EPIDEMIOLOGY; MUTATION; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PREGNANCY; PREVALENCE;

EID: 84942313095     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu467     Document Type: Article

References (31)

1. Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol 2009;7:864-74.
2. WHO. World malaria report 2011. Geneva: World Health Organization, 2012.
3. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmo-dium falciparum malaria. N Engl J Med 2009;361:455-67.
4. Phyo AP, Nkhoma S, Stepniewska K, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012;379:1960-6.
5. Lon C, Manning JE, Vanachayangkul P, et al. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial. PLoS One 2014;9:e93138.
6. Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014;505:50-5.
7. Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ. Genome editing in the human malaria parasite Plasmo-dium falciparum using the CRISPR-Cas9 system. Nat Biotechnol 2014;32:819-21.
8. White NJ. Malaria: a molecular marker of artemisinin resistance. Lancet 2014;383:1439-40.
9. Dorsey G, Staedke S, Clark TD, et al. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 2007;297:2210-9.
10. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med 2011;8:e1001119.
11. Lopera-Mesa TM, Doumbia S, Chiang S, et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis 2013;207:1655-63.
12. Maiga AW, Fofana B, Sagara I, et al. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg 2012;87:23-8.
13. Taylor SM, Parobek CM, Aragam N, et al. Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes. J Infect Dis 2013;208:1998-2006.
14. Vinayak S, Alam MT, Mixson-Hayden T, et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog 2010;6:e1000830.
15. Bailey JA, Mvalo T, Aragam N, et al. Use of massively parallel pyrose-quencing to evaluate the diversity of and selection on Plasmodium fal-ciparum csp T-Cell epitopes in Lilongwe, Malawi. J Infect Dis 2012;206:580-7.
16. Rantala AM, Taylor SM, Trottman PA, et al. Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malar J 2010;9:269.
17. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9:357-9.
18. Li H, Handsaker B, Wysoker A, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078-9.
19. Consortium M. P.falciparum Community Project 2014. http://www.malariagen. net/apps/pf/2.0/. Accessed 10 March 2014.
20. Vandenhende MA, Bellecave P, Recordon-Pinson P, et al. Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure. PLoS One 2014;9:e86771.
21. Gibson RM, Meyer AM, Winner D, et al. Sensitive deep sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism. Antimicrob Agents Chemother 2014;58:2167-85.
22. Nei M, Tajima F, Tateno Y. Accuracy of estimated phylogenetic trees from molecular data. II. Gene frequency data. J Mol Evol 1983;19:153-70.
23. Liu K, Muse SV. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005;21:2128-9.
24. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30:2725-9.
25. Paradis E, Claude J, Strimmer K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 2004;20:289-90.
26. Wootton JC, Feng X, Ferdig MT, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002;418:320-3.
27. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004;305:1124.
28. Pearce RJ, Pota H, Evehe MS, et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med 2009;6:e1000055.
29. Singh A, Misra V, Thimmulappa RK, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 2006;3:e420.
30. WHO. Global plan for artemisinin resistance containment. Geneva: World Health Organization, 2011.
31. Vestergaard LS, Ringwald P. Responding to the challenge of antimalar-ial drug resistance by routine monitoring to update national malaria treatment policies. Am J Trop Med Hyg 2007;77:153-9.